TFDA takes actions to expedite the development of COVID-19 vaccines
Main Authors: | Sam Chi-Hao Liu, Chia-Ping Liu, Chien-Liang Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-04-01
|
Series: | Journal of the Formosan Medical Association |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664621001030 |
Similar Items
-
TFDA takes actions to help mitigate supply disruptions or shortages of drug
by: Sam Chi-Hao Liu, et al.
Published: (2020-10-01) -
Will Africans take COVID-19 vaccination?
by: AbdulAzeez A Anjorin, et al.
Published: (2021-01-01) -
Four actions Australia should take to advance equitable global access to COVID‐19 vaccines
by: Deborah Gleeson, et al.
Published: (2022-08-01) -
Expedited COVID-19 vaccine trials: a rat-race with challenges and ethical issues
by: Prathamesh Haridas Kamble, et al.
Published: (2020-07-01) -
Pandemic vaccine trials: expedite, but don’t rush
by: Angus Dawson
Published: (2020-07-01)